Cite
HARVARD Citation
Calafat, M. et al. (n.d.). P437 Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease: a cohort study of the ENEIDA registry. Journal of Crohn's and colitis. pp. S328-S329. [Online].